Last update 12 Jun 2025
Future Homo Sapiens Institute of Regenerative Medicine (Guangzhou) Co., Ltd.

Future Homo Sapiens Institute of Regenerative Medicine (Guangzhou) Co., Ltd.

Private Company | Subsidiary Company|2019|Guangdong Sheng, China

Overview

Tags

Neoplasms
Nervous System Diseases
Other Diseases
Exosomes

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms3
Nervous System Diseases1
Top 5 Drug TypeCount
Exosomes4
Top 5 TargetCount
VEGF-A(Vascular endothelial growth factor A)1
PCSK9(Proprotein convertase subtilisin kexin type 9)1
NR4A1(nuclear receptor subfamily 4 group A member 1)1
IRF1(interferon regulatory factor 1)1

Related

4
Drugs associated with Future Homo Sapiens Institute of Regenerative Medicine (Guangzhou) Co., Ltd.
CN114657136
Patent Mining
Target
PCSK9
Mechanism-
Active Org.
Future Homo Sapiens Institute of Regenerative Medicine (Guangzhou) Co., Ltd.Future Homo Sapiens Institute of Regenerative Medicine (Guangzhou) Co., Ltd.
Originator Org.
Future Homo Sapiens Institute of Regenerative Medicine (Guangzhou) Co., Ltd.Future Homo Sapiens Institute of Regenerative Medicine (Guangzhou) Co., Ltd.
Active Indication
Germ Cell and Embryonal Neoplasms
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
CN114717232
Patent Mining
Target
IRF1
Mechanism-
Active Org.
Future Homo Sapiens Institute of Regenerative Medicine (Guangzhou) Co., Ltd.Future Homo Sapiens Institute of Regenerative Medicine (Guangzhou) Co., Ltd.
Originator Org.
Future Homo Sapiens Institute of Regenerative Medicine (Guangzhou) Co., Ltd.Future Homo Sapiens Institute of Regenerative Medicine (Guangzhou) Co., Ltd.
Active Indication
Other Diseases [+1]
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
CN114645020
Patent Mining
Target
NR4A1
Mechanism-
Active Org.
Future Homo Sapiens Institute of Regenerative Medicine (Guangzhou) Co., Ltd.Future Homo Sapiens Institute of Regenerative Medicine (Guangzhou) Co., Ltd.
Originator Org.
Future Homo Sapiens Institute of Regenerative Medicine (Guangzhou) Co., Ltd.Future Homo Sapiens Institute of Regenerative Medicine (Guangzhou) Co., Ltd.
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Future Homo Sapiens Institute of Regenerative Medicine (Guangzhou) Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Future Homo Sapiens Institute of Regenerative Medicine (Guangzhou) Co., Ltd.
Login to view more data
100 Deals associated with Future Homo Sapiens Institute of Regenerative Medicine (Guangzhou) Co., Ltd.
Login to view more data
100 Translational Medicine associated with Future Homo Sapiens Institute of Regenerative Medicine (Guangzhou) Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 30 Jul 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
4
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
CN114657130
 ( VEGF-A )Patent Mining		Neoplasms
More
Discovery
CN114717232
 ( IRF1 )Patent Mining		Psychotic Disorders
More
Discovery
CN114657136
 ( PCSK9 )Patent Mining		Germ Cell and Embryonal Neoplasms
More
Discovery
CN114645020
 ( NR4A1 )Patent Mining		Neoplasms
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free